Literature DB >> 30191736

Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing.

Zhu Kun-Peng1,2, Ma Xiao-Long1,2, Zhang Lei1,2, Zhang Chun-Lin1,2, Hu Jian-Ping1,2, Zhan Tai-Cheng1,2.   

Abstract

AIM: To identify circular RNAs (circRNAs) related to osteosarcoma (OS) chemoresistance. MATERIALS &
METHODS: CircRNA expression profile was performed in three paired human chemoresistant and chemosensitive OS cell lines by next-generation sequencing. Quantitative real-time-PCR (qRT-PCR) was used to confirm next-generation sequencing data. Bioinformatics analysis was conducted to predict their functions.
RESULTS: Eighty circRNAs were dysregulated in the chemoresistant OS cells compared with the control, after validated by qRT-PCR. Bioinformatics analysis showed that some pathways related to drug metabolism were significantly enriched. Additionally, hsa_circ_0004674 was distinctly increased in OS chemoresistant cells and tissues, related to poor prognosis. CircRNA-miRNA-mRNA pathways related to hsa_circ_0004674 were constructed by TargetScan and miRanda.
CONCLUSION: CircRNAs may play a role in OS chemoresistance and hsa_circ_0004674 might be a candidate target.

Entities:  

Keywords:  chemoresistance; circRNA; osteosarcoma

Mesh:

Substances:

Year:  2018        PMID: 30191736     DOI: 10.2217/epi-2018-0023

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  26 in total

1.  Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.

Authors:  Guoli Shao; Xulong Fan; Pusheng Zhang; Xuewen Liu; Lei Huang; Shufeng Ji
Journal:  Cell Biol Toxicol       Date:  2022-07-23       Impact factor: 6.819

2.  Cisplatin resistance-associated circRNA_101237 serves as a prognostic biomarker in hepatocellular carcinoma.

Authors:  Shuping Zhou; Juan Wei; Yeliu Wang; Xinkuang Liu
Journal:  Exp Ther Med       Date:  2020-02-12       Impact factor: 2.447

3.  Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion.

Authors:  Yi-Xin Du; Lin-Xin Guo; Han-Song Pan; Yi-Min Liang; Xiang Li
Journal:  Hum Cell       Date:  2019-10-30       Impact factor: 4.174

Review 4.  Circular RNAs: new biomarkers of chemoresistance in cancer.

Authors:  Jiaqi Wang; Yi Zhang; Lianyu Liu; Ting Yang; Jun Song
Journal:  Cancer Biol Med       Date:  2021-03-19       Impact factor: 4.248

5.  CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760.

Authors:  Jianjun Yuan; Yan Liu; Quan Zhang; Zhishuai Ren; Guang Li; Rong Tian
Journal:  Cancer Manag Res       Date:  2021-06-02       Impact factor: 3.989

6.  Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines.

Authors:  Chunjie Wen; Ge Xu; Shuai He; Yutang Huang; Jingjing Shi; Lanxiang Wu; Honghao Zhou
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

Review 7.  Emerging important roles of circRNAs in human cancer and other diseases.

Authors:  Yong Huang; Cai Zhang; Jianli Xiong; Hongtao Ren
Journal:  Genes Dis       Date:  2020-08-07

8.  Upregulation Of circMMP9 Promotes Osteosarcoma Progression Via Targeting miR-1265/CHI3L1 Axis.

Authors:  Guangjie Pan; Ting Hu; Xuewu Chen; Chao Zhang
Journal:  Cancer Manag Res       Date:  2019-10-29       Impact factor: 3.989

Review 9.  Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance.

Authors:  Chaochu Cui; Jianbo Yang; Xiao Li; Dongling Liu; Liwu Fu; Xianwei Wang
Journal:  Mol Cancer       Date:  2020-03-14       Impact factor: 27.401

10.  circ_0005962 functions as an oncogene to aggravate NSCLC progression.

Authors:  Zhihong Zhang; Zhenxiu Shan; Rubin Chen; Xiaorong Peng; Bin Xu; Liang Xiao; Guofei Zhang
Journal:  Open Med (Wars)       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.